| ACPA |
Anti-citrullinated protein antibody |
| CRP |
C-reactive protein |
| DMARD |
Disease modifying anti-rheumatic drug |
| ECM |
Extracellular matrix |
| ESR |
Erthrocyte sedimentation rate |
| FLS |
Fibroblast-like synoviocyte |
| GM-CSF |
Granulocyte-macrophage colony-stimulating factor |
| IFN-
|
Interferon-
|
| IFX |
Infliximab |
| IL-‘x’ |
Interleukin-‘x’ |
| MMP |
Matrix metalloproteinase |
| MTX |
Methotrexate |
| NF-B |
Nuclear factor- B |
| NSAID |
Non-steroidal anti-inflammatory drug |
| ODE |
Ordinary differential equation |
| PDE |
Partial differential equation |
| RA |
Rheumatoid arthritis |
| RANK(L) |
Receptor activator of NF-B (ligand) |
| TCZ |
Tocilzumab |
| TIMP |
Tissue inhibitor of metalloproteinase |
| TNF-
|
Tumour necrosis factor-
|
| TNFi |
TNF- inhibitor |